The following is a summary of “Nomogram for predicting proliferative lupus nephritis in patients with low-level proteinuria,” ...

The course is specifically designed for nephrologists to teach them what they need to know about the renal biopsy and how it affects management. The course lasts 2 full days and comprises didactic ...

Lung biopsy is a relatively frequently performed procedure with considerable benefit for patient management but it may, on rare occasions, result in the death of the patient. It is a multidisciplinary ...

Routine self-exams and mammograms are important to keep your breasts healthy. If an abnormality is found, your doctor might order a biopsy to see a more detailed view of the breast tissue. An ...

OpenAI just released o3-mini, a reasoning model that’s faster, cheaper, and more accurate than its predecessor. On Thursday, Microsoft announced that it’s rolling OpenAI's reasoning model o1 ...

Get the full experience! Unlock access to all videos with the Unlimited Trains.com Membership.

Ozempic becomes the first GLP-1 treatment option for people with type 2 diabetes and chronic kidney disease Mario Tama/Getty The Food and Drug Administration has approved Ozempic to reduce the ...

Jan. 28, 2025 — A data analysis from a randomized clinical trial for stage 3 colon cancer patients found that patients with evidence of residual cancer in their blood after surgery to remove the ...

Jan. 22, 2025 — New guidelines will help doctors identify patients with a common memory-loss syndrome that is often misdiagnosed as Alzheimer's disease in older ... Antibiotics, Vaccinations and ...

Change from baseline endpoints were analysed by analysis of covariance model with baseline measurement and the stratification factors ... patients with baseline UPCR ≥3 and those with class IV (as ...

What especially shook investors was the prospect that China may have closed the tech gap with the United States in AI and especially DeepSeek’s claim that it developed R1 for just $5.6 million—a far ...

The methylation of plasma cell-free DNA (cfDNA) has emerged as a valuable diagnostic and prognostic biomarker in various cancers including colorectal cancer (CRC). Currently, there are no biomarkers ...